Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Als symbols : SNY save search
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Published: 2024-04-15 (Crawled : 05:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.53%
H: 0.61%
C: 0.61%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.95%
H: 0.0%
C: 0.0%
drug als biomarker
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
Published: 2024-04-03 (Crawled : 16:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: 0.0%
health als granted canada
ALS Treatment Landscape ‘Primed’ with Over 100 Candidates: GlobalData
Published: 2024-03-04 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.8%
H: 0.0%
C: 0.0%
als treatment 100
Sanofi, Denali ALS Candidate Flops in Mid-Stage Trial
Published: 2024-02-19 (Crawled : 13:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
candidate als trial
$350M Funding Breaths New Life into Former ALS Compound for Asthma
Published: 2022-07-12 (Crawled : 15:20) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.3%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.33%
H: 0.0%
C: 0.0%
life als funding
Denali/Sanofi ALS Candidate Hits Phase II as Awareness Month Begins
Published: 2022-05-03 (Crawled : 15:00) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 1.21%
H: 0.0%
C: 0.0%
als
Denali Therapeutics Announces Achievement of RIPK1 Milestone for Phase 2 Clinical Trial Initiation in ALS by Sanofi
Published: 2022-05-02 (Crawled : 13:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.08%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -2.05%
H: 0.0%
C: 0.0%
DNLI | $15.98 -3.74% -3.88% 1.5M
|
Health Technology
|
| O: -6.34%
H: 6.77%
C: 6.48%
als trial therapeutics sanofi milestone phase 2
Global Generic Injectables Market Research Report 2022: Expiration of Branded Drug Patents & Rising Approvals for Generic Injectable Drugs
Published: 2022-03-15 (Crawled : 23:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: 0.87%
H: 0.27%
C: -0.51%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.82%
H: 0.0%
C: 0.0%
als drug patent research approval report
Avadel Pharmaceuticals Announces Appointment of Brandi Robinson as Senior Vice President, Corporate Affairs
Published: 2022-03-14 (Crawled : 21:00) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.03%
H: 3.21%
C: 3.21%
RFL 4 | $1.76 2.92% 0.0% 26K
|
Finance
|
| O: 0.48%
H: 4.27%
C: -0.47%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 3.07%
H: 0.0%
C: 0.0%
AVDL | $17.33 -0.29% -0.29% 1.3M
|
Health Technology
|
| O: -10.18%
H: 4.38%
C: 4.08%
als ces air
Imbria Pharmaceuticals Strengthens Executive Leadership Team with New Appointments
Published: 2022-03-10 (Crawled : 23:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 2.52%
H: 1.67%
C: 1.67%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.12%
H: 0.0%
C: 0.0%
als
Long term study confirms efficacy of ISA Pharmaceuticals' T-cell activating immunotherapy in combination with checkpoint inhibitor
Published: 2022-03-01 (Crawled : 09:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -3.33%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.3%
H: 0.0%
C: 0.0%
als long term cel immunotherapy therapy t-cell
Pause of GSK's RSV Vaccine Trials in Pregnant Women Deepens
Published: 2022-02-28 (Crawled : 15:00) - biospace.com/
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 1.79%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.49%
H: 0.0%
C: 0.0%
als trials trial women vaccine
Rhythm Pharmaceuticals Announces Promotions within its Executive Leadership Team
Published: 2022-02-23 (Crawled : 13:00) - globenewswire.com
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 2.09%
H: 0.08%
C: -1.22%
RYTM A | $37.975 -0.35% -0.36% 620K
|
Health Technology
|
| O: 0.24%
H: 3.81%
C: -0.24%
als ces
Azurity Pharmaceuticals Announces Richard Blackburn as New CEO
Published: 2022-02-18 (Crawled : 12:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: -0.23%
H: 0.0%
C: -6.31%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.47%
H: 0.77%
C: -0.23%
als ces new ceo ceo
Global Roundup: Genuv Adds AI to Aid Discovery of Alzheimer's, ALS Therapies
Published: 2022-02-17 (Crawled : 13:30) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.69%
H: 0.0%
C: -0.23%
TRIB | $1.81 -3.72% -3.87% 5.7K
|
Health Technology
|
| O: 0.88%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -1.4%
H: 0.76%
C: 0.17%
OPT | $3.4 0.29% 3.7K
|
Health Technology
|
| O: -0.66%
H: 0.0%
C: 0.0%
ACIU | $2.375 -0.21% -0.21% 320K
|
Health Technology
|
| O: -1.08%
H: 0.0%
C: -2.19%
alzheimer als alzheimer’s therapy alzheimer's
Alnylam Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Highlights Recent Period Activity
Published: 2022-02-10 (Crawled : 13:30) - biospace.com/
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.92%
H: 0.0%
C: 0.0%
IONS | $40.64 -0.42% -0.42% 850K
|
Health Technology
|
| O: 0.7%
H: 3.82%
C: 0.78%
ALNY | $144.315 -0.58% -0.59% 700K
|
Health Technology
|
| O: -0.66%
H: 6.03%
C: 1.83%
als financial results report results
Worldwide Hospital Services Industry to 2027 - Rising Investment in Healthcare Infrastructure and Professionals Presents Opportunities
Published: 2022-01-14 (Crawled : 12:30) - prnewswire.com
THC | $93.19 2.32% 0.0% 1.1M
|
Health Services
|
| O: 1.58%
H: 0.0%
C: 0.0%
MDT | $79.48 0.37% -0.29% 6.7M
|
Health Technology
|
| O: -0.7%
H: 0.0%
C: 0.0%
PHG | $19.98 0.0% 540K
|
Health Technology
|
| O: 2.51%
H: 0.0%
C: 0.0%
GE | News | $148.06 -3.19% 0.0% 9.5M
|
Electronic Technology
|
| O: -0.9%
H: 0.0%
C: 0.0%
CYH | $2.86 2.88% 0.0% 2M
|
Health Services
|
| O: 1.09%
H: 0.0%
C: 0.0%
BDX | $234.12 0.42% 0.0% 1.3M
|
Health Technology
|
| O: -0.1%
H: 0.0%
C: 0.0%
A | $132.73 0.22% 0.0% 1.3M
|
Health Technology
|
| O: -3.36%
H: 0.0%
C: 0.0%
MMM | $92.27 0.86% -0.18% 3.6M
|
Producer Manufacturing
|
| O: -0.09%
H: 0.0%
C: -1.17%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.96%
H: 0.0%
C: 0.0%
health als ces thc services
Global Big Pharma Partnering Deals Directory 2021
Published: 2022-01-12 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: -0.14%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: -0.74%
H: 0.0%
C: 0.0%
als deal pharma
Escient Pharmaceuticals Appoints Joshua Grass, MBA as CEO
Published: 2022-01-05 (Crawled : 14:00) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
CERS | $1.675 2.13% 2.09% 980K
|
Health Technology
|
| O: -1.06%
H: 1.23%
C: -4.6%
als ceo
Crinetics Pharmaceuticals Adds Board Member with Global Rare Disease Expertise with Appointment of Rogério Vivaldi Coelho, M.D., M.B.A.
Published: 2022-01-05 (Crawled : 12:30) - globenewswire.com
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 3.68%
H: 0.0%
C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M
|
Health Technology
|
| O: 0.91%
H: 0.0%
C: 0.0%
CRNX | $42.98 -0.07% -0.07% 620K
|
Health Technology
|
| O: -0.57%
H: 1.86%
C: -2.46%
als disease rare
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.